A removable peripheral device for intracerebral microinjection in freely moving rats.

Brain Res Brain Res Protoc

A.A. Bogomoletz Institute of Physiology, National Academy of Sciences of the Ukraine, Kiev, Ukraine.

Published: December 1997

This report describes an original, removable, peripheral device: a microinjector that injects a single dose of fluid chemical into a particular site in the brain of freely moving rats. The microinjector was constructed especially for simultaneous use with a microdrive for microelectrode recording of single neuron activity but can be utilized alone. The microinjector is simple, lightweight, small, and easy to operate and maintain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1385-299x(97)00024-xDOI Listing

Publication Analysis

Top Keywords

removable peripheral
8
peripheral device
8
freely moving
8
moving rats
8
device intracerebral
4
intracerebral microinjection
4
microinjection freely
4
rats report
4
report describes
4
describes original
4

Similar Publications

Advanced and uneven residual ridge resorption in mandibular edentulous arches leads to non-retentive and unstable dentures. The hardness of traditional heat-cured acrylic resin makes extending the denture base into bilateral lingual undercuts challenging. This can cause supporting tissue damage, pain, and ulcerations during denture insertion and removal.

View Article and Find Full Text PDF

Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year.

J Clin Med

March 2024

Division of Endocrinology and Diabetology, Department of Medical Sciences, Fondazione Policlinico "Tor Vergata", 00133 Rome, Italy.

Article Synopsis
  • - The study analyzed diabetic patients with Charcot neuro-osteoarthropathy (CNO), a serious complication of diabetes, being treated at a specialized diabetic foot clinic from early 2019 to late 2022.
  • - Out of 43 patients, the average age was around 57, predominantly male, and most had type 2 diabetes for over 20 years, with a significant portion also having peripheral artery disease.
  • - Results showed a high remission rate of 93% after treatment, with an average remission time of about 5.6 months, and very low rates of major amputations (2.3%) or surgical interventions (7%).
View Article and Find Full Text PDF

Objective: To explore whether menstrual blood collected via a modified menstrual pad is a surrogate for venous blood drawn in analyzing hemoglobin A1c (HbA1c) and fertility-associated hormones.

Design: Cross-sectional study.

Setting: Clinical testing laboratory.

View Article and Find Full Text PDF

The 1989 Saint Vincent Declaration established a goal of halving global diabetes-related amputation rates. A generation later, this goal has been achieved for major but not minor amputations. However, diabetic foot disease (DFD) is not only a leading cause of global amputation but also of hospitalisation, poor quality of life (QoL) and disability burdens.

View Article and Find Full Text PDF

Diabetic foot ulcer non-reimbursed treatment depends on multiple factors, including the patient's buying behaviors. Factors affecting buying behaviors for the removable off-loading devices are not completely understood. The aim of this study was to investigate the patients' buying behaviors of the removable off-loading devices and their influence on the DFU treatment outcomes remotely monitored during the COVID-19 pandemic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!